COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension ...

ID
39373511000001104
Virtual product
Generic COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials
Name
COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials
Abbreviated name
COVID-19 Vaccine Valneva 0.5ml inj multidose vials
Description
COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials (Valneva UK Ltd)
Date of name applicability
16 Mar 2021
Previous Name
COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5mL dose suspension for injection multidose vials
Supplier
Valneva UK Ltd
Licensed as
Medicines - MHRA/EMA
Previously licensed as
None
License change reason
Licence Granted
Date of change of licensing authority
21 Nov 2022
EMA (European Medicines Agency) Monitoring
1
Restrictions on availability
Restricted Availability
Licensed route
Intramuscular